CAR T-Cell Therapy in Metastatic CRPC and Future Directions

Closing out their final module, expert panelists consider the role of CAR T-cell therapy in metastatic castration-resistant prostate cancer and look toward future evolutions in the broader treatment landscape.

Related Keywords

, Treatment Approaches , Prostate Cancer , Cell Therapy , Future Directions , Metastatic Prostate Cancer , Nmcrpc , Castration Resistant Prostate Cancer , Cart Therapy , Cart Cell Therapyt Bispecifics , Bispecific Therapy , Clinical Trials , Asco 2023 , Asco Annual Meeting ,